Eyemole

Melanoma Screening Technology

Health Tech & Life Sciences
Non Active, Nov 2016
Pre-Funding Hinanit, Israel Founded 2008
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2008
Headcount
6
HQ
Hinanit, Israel
Sector
Health Tech & Life Sciences

About

EyeMole is developing a melanoma-screening technology with related software solutions using tele-dermatology techniques. EyeMole's goal is to empower dermatologists with a readily available and easy-to-perform automated screening procedure, providing tangible benefits to hospitals, health funds, dermatologists, and people with a medium-to-high risk of contracting melanoma.

Q&A

What is Eyemole's primary business focus?
Eyemole is developing a melanoma-screening technology with related software solutions using tele-dermatology techniques.
When was Eyemole founded?
Eyemole was founded in January 2008.
What is the current status of Eyemole?
Eyemole is currently inactive, as of November 2016.
Who is the founder and CEO of Eyemole?
Avi Mendelson is the Founder and CEO of Eyemole.
What sector does Eyemole primarily operate in?
Eyemole's primary sector is Health Tech & Life Sciences.
What is Eyemole's current funding stage?
Eyemole is in the Pre-Funding stage.

Team · 1

Founder · Founder, CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

dermatologymedical-devicesmedical-productssoftware-applicationsdiagnosticscancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2008-1
Employees (exact)6
Status reasonNon Active, Nov 2016